Thalys Medical Technology Group Corporation

Thalys Medical Technology provides medical integrated operation and management services in China. It offers automated immunofluorescence analyzer. Its portfolio also includes coagulation reagent, COVID-19 test kit, line blot1 fully automated immunoblotting instrument, and flow products, as well as automated coagulation analyzer. Its portfolio also includes automated immunoassay system, automated biochemical analysis system, automated chemiluminescence immunoassay system, and blood analyzer. Founded in 2004 and headquartered in Wuhan, China, Thalys Medical Technology was formerly known as Thalys Medical Technology Inc. before rebranding in September 2020.